Harris Williams advised Lintbells, a portfolio company of Inflexion, a leading European mid-market private equity firm, on their pending sale to Vetnique Labs, a portfolio company of Gryphon Investors. Lintbells, home of YuMOVE, is a globally recognized leader in pet supplements.
U.K.-based Lintbells provides pets and their owners with scientifically supported supplements to address chronic health conditions. Their products are sold under the YuMOVE brand umbrella and include supplements to help joint mobility, digestive health, anxiety, skin and coat, and dental health for dogs and cats.
Lintbells experienced significant growth under Inflexion’s ownership, including the successful expansion of their direct-to-consumer channel and the company’s entrance into the U.S. Lintbells also achieved B Corp accreditation in early 2024 to recognize the company’s commitment to ESG.
The large, growing, and resilient pet health space continues to be a highly attractive sector for investors. The market is supported by multiple favorable tailwinds, including growing pet ownership, aging of the COVID-19 pet cohort, improving detection and diagnosis of pet health conditions, and increasing use of preventative treatments.
Combining the complementary Lintbells and Vetnique Labs product portfolios and leveraging the new group’s resources and expertise creates a global pet health and wellness platform of scale, driving accelerated profitable growth across the U.S., the U.K., and other international markets. The new group brings science-backed formulations, clinical efficacy, and vet-recommended, patented products to consumers worldwide, while achieving their mission of enhancing quality of life for pets.
Contact the Harris Williams Consumer Group to learn more about this client engagement.
